C. Difficile

>

Latest News

A Clinician’s Perspective on Rebyota for Recurrent C Diff Treatment
A Clinician’s Perspective on Rebyota for Recurrent C Diff Treatment

October 23rd 2024

Timothy Ritter, MD, provides his insights on using the live biotherapeutic product and what both patients and clinicians can expect in terms of safety and efficacy.

Targeted Prophylaxis Reduces Hospital-Onset C difficile Infections in High-Risk Patients
Targeted Prophylaxis Reduces Hospital-Onset C difficile Infections in High-Risk Patients

October 22nd 2024

Real World Study of Recurrent Clostridioides difficile Therapy Demonstrates Efficacy, Safety
Real World Study of Recurrent Clostridioides difficile Therapy Demonstrates Efficacy, Safety

October 16th 2024

New Insights into Clostridioides difficile Infection and Vaccine Development
New Insights into Clostridioides difficile Infection and Vaccine Development

October 14th 2024

Top 5 Infectious Disease News Stories Week of September 27-October 4
Top 5 Infectious Disease News Stories Week of September 27-October 4

October 5th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.